Skip to main content
. 2022 Jun 13;22:227. doi: 10.1186/s12890-022-02017-8

Table 2.

Variables at baseline and 2 h after HFNC therapy initiation

HFNC success (n = 51) HFNC failure (n = 24) value
Baseline HR [mean ± SD, bpm] 102 ± 18 116 ± 17 0.001
Baseline RR [mean ± SD, cpm] 25 ± 5 28 ± 6 0.015
Baseline FiO2 [mean ± SD] 0.5 ± 0.2 0.5 ± 0.2 0.641
Baseline SpO2 [mean ± SD, %] 95.0 ± 4.0 93.2 ± 6.1 0.140
Baseline PaO2 [M(P25, P75), mmHg] 70.0 (61.0–84.0) 69.8 (60.4–75.4) 0.222
Baseline PaCO2 [mean ± SD, mmHg] 37.4 ± 7.7 34.2 ± 6.5 0.080
Baseline PF ratio [M(P25, P75)] 142.5 (123.6–188.4) 138.0 (114.5–171.5) 0.214
Baseline lactate [mean ± SD, mmol/l] 2.0 ± 1.2 2.7 ± 1.9 0.044
2 h HR [mean ± SD,bpm] 99 ± 17 113 ± 16 0.001
2 h RR [M(P25, P75),bpm] 21 (19–25) 27 (23–35) 0.001
2 h FiO2 [M(P25, P75)] 0.55 (0.50–0.60) 0.69 (0.60–0.89) 0.001
2 h Flow on HFNC [mean ± SD, L/min] 49.7 ± 7.7 52.1 ± 8.2 0.226
2 h SpO2 [M(P25, P75)] 98.0 (96.0–100.0) 95.0 (89.5–97.8) 0.002
2 h PaO2 [mean ± SD, mmHg] 106.7 ± 41.5 75.3 ± 25.2 0.001
2 h PaCO2 [mean ± SD, mmHg] 35.9 ± 8.4 34.2 ± 6.0 0.386
2 h PF ratio [M(P25, P75)] 178.0 (126.0–251.7) 95.7(68.6–131.7) 0.000
2 h lactate [M(P25, P75), mmol/l] 1.4 (1.0–2.0) 2.3(1.7–3.6) 0.001

Annotation: HR, heart rate; RR, respiratory rate; FiO2, fraction of inspiration O2; SpO2,saturation of pulse oxygen ; PaO2, arterial oxygen partial pressure; PaCO2, arterial carbon dioxide partial pressure; PF ratio, PaO2/FiO2; cpm, counts per minute; bpm, beats per minute; P25, 25th percentile; P75, 75th percentile; HFNC, high-flow nasal cannula